[JP16] Poster Presentation 16

[JP-123] Part A results from the ongoing DEVOTE study to explore higher-dose nusinersen in SMA

Yosuke Tachibana (1. バイオジェン・ジャパン、2. Department of Paediatric Neurology、 Catholic University、 Rome、 Italy、3. Center for Experimental Neurotherapeutics、 St. Jude Children's Research Hospital、 Memphis、 TN、 USA、4. Department of Neurology、 Stanford University School of Medicine、 Stanford、 CA、 USA、5. UAM Serv. Neurologia Pediatrica、 Hospital Universitario La Paz、 Madrid、 Spain、6. Department of Neurology、 Royal Children's Hospital and Murdoch Children's Research Institute、 and University of Melbourne、 Parkville、 Victoria、 Australia、7. Departments of Neurology and Pediatrics、 Columbia University Irving Medical Center、 New York、 NY、 USA、8. Departments of Rehabilitation and Regenerative Medicine and Neurology、 Columbia University Irving Medical Center、 New York、 NY、 USA、9. Department of Paediatrics、 Universidade Federal de Minas Gerais、 Belo Horizonte、 Brazil、10. Biogen、 Cambridge、 MA、 USA)